Search Results - "Parouchev, Alexandre"
-
1
Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction
Published in Journal of the American College of Cardiology (30-01-2018)“…In addition to scalability, human embryonic stem cells (hESCs) have the unique advantage of allowing their directed differentiation toward lineage-specific…”
Get full text
Journal Article -
2
Circadian Clock Genes Modulate Human Bone Marrow Mesenchymal Stem Cell Differentiation, Migration and Cell Cycle
Published in PloS one (07-01-2016)“…Many of the components that regulate the circadian clock have been identified in organisms and humans. The influence of circadian rhythm (CR) on the regulation…”
Get full text
Journal Article -
3
Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1
Published in European heart journal (07-08-2015)Get full text
Journal Article -
4
Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report
Published in European heart journal (07-08-2015)“…Comparative studies suggest that stem cells committed to a cardiac lineage are more effective for improving heart function than those featuring an…”
Get full text
Journal Article -
5
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock
Published in Cell cycle (Georgetown, Tex.) (02-01-2018)“…Everolimus (EV), a rapamycin analogue mTOR inhibitor, is used in the clinic to treat Estrogen positive (ER ) breast cancer in order to avoid the resistance to…”
Get full text
Journal Article -
6
Circadian Clock Genes Modulate Human Bone Marrow Mesenchymal Stem Cell Differentiation, Migration and Cell Cycle: e0146674
Published in PloS one (01-01-2016)“…Many of the components that regulate the circadian clock have been identified in organisms and humans. The influence of circadian rhythm (CR) on the regulation…”
Get full text
Journal Article -
7
Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization
Published in Transplantation (27-10-2006)“…Hepatocyte transplantation could be an alternative to whole liver transplantation for the treatment of metabolic liver diseases. However, the results of…”
Get full text
Journal Article -
8
In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system—initial experience in mice
Published in European radiology (01-01-2008)“…The feasibility of in vitro mature mouse hepatocyte labeling with a novel iron oxide particle was assessed and the ability of 1.5-T magnetic resonance imaging…”
Get full text
Journal Article -
9
Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer
Published in Oncogene (20-01-2005)“…Hepatoblasts are bipotent progenitors of both hepatocytes and cholangiocytes. The lack of stable in vitro culture systems for such cells makes it necessary to…”
Get full text
Journal Article -
10
Efficient ex vivo gene transfer into non-human primate hepatocytes using HIV-1 derived lentiviral vectors
Published in Journal of hepatology (01-07-2006)“…Lentivirus-mediated ex vivo gene therapy is becoming a promising approach for the treatment of liver metabolic disorders. However, the feasibility of this…”
Get full text
Journal Article -
11
Primate hepatic foetal progenitor cells and their therapeutic potential : Stem cells
Published in Pathologie biologie (Paris) (2006)Get full text
Journal Article -
12
Primate hepatic foetal progenitor cells and their therapeutic potential
Published in Pathologie biologie (Paris) (01-03-2006)“…Transplantation of genetically modified or unmodified hepatocytes appears to be a less invasive alternative to liver transplantation. However, clinical trials…”
Get full text
Journal Article -
13
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock
Published in Cell Cycle (02-01-2018)“…Everolimus (EV), a rapamycin analogue mTOR inhibitor, is used in the clinic to treat Estrogen positive (ER + ) breast cancer in order to avoid the resistance…”
Get full text
Report